EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Convergence of Carbapenem and Colistin Resistance in Intestinal Escherichia coli ST167/ST2659 Driven by IncX3 blaNDM-5 and IncI2-Associated Mcr-1.1 Mobility

Lianmin Bao, Tongxi Hu iD, Qing Zhang, Heping Lin, Hanhan Yan, Han Gao, Xiaojing Liu, Zongxiao Shangguan

Infection and Drug Resistance · 2026-05 · Volume 19 · 1-8

DOI: 10.2147/idr.s594479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-05. Verfasst von Lianmin Bao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, People's Republic of China. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Intestinal colonization by multidrug-resistant Escherichia coli provides a silent reservoir for dissemination of last-line resistance. The co-occurrence of bla NDM-5 and the plasmid-mediated colistin resistance gene mcr-1.1 is particularly concerning, yet the plasmid architectures and transfer potential of colonizing isolates remain poorly characterized.

Methods

Two bla NDM-5 - and mcr-1.1 -positive E. coli isolates were recovered from fecal samples during colonization screening were investigated (L1771 and L2386). Antimicrobial susceptibility was determined by MIC testing. Short- and long-read sequencing was used to achieve plasmid-level resolution. S1-nuclease PFGE and Southern blot hybridization were performed to localize resistance genes. Conjugation assays were conducted to evaluate plasmid transferability.

Results

Both isolates were resistant to colistin (MIC 4 mg/L) and carbapenems (L1771: imipenem 32 mg/L, meropenem 32 mg/L; L2386: imipenem 16 mg/L, meropenem 16 mg/L). L1771 contained a bla NDM-5 -carrying IncX3 plasmid (~46 kb), whereas mcr-1.1 was located on the chromosome. In contrast, plasmid-resolved analysis of L2386 revealed a high-risk configuration involving two distinct resistance plasmids: a bla NDM-5 -carrying IncX3 plasmid (~48 kb) and an mcr-1.1 -carrying IncI2 plasmids (~65 kb). Together, these plasmids formed a multi-plasmid “last-line resistance package” linking carbapenem and colistin resistance within a single isolate. The IncI2 mcr-1.1 plasmid p2803-MCR co-carried bla CTX-M-199 . Importantly, all three resistance plasmids identified above: the bla NDM-5 -carrying IncX3 plasmid in L1771 and the bla NDM-5 -carrying IncX3 plasmid together with the mcr-1.1 -carrying IncI2 plasmid in L2386 were transferable by conjugation, supporting strong potential for horizontal spread and co-selection.

Conclusion

This study provides plasmid-resolved and functionally validated evidence that gut-colonizing E. coli can assemble a fully conjugative, multi-plasmid resistance package linking carbapenem and colistin resistance, including an IncI2 mcr-1.1 platform with potential broad-host-range dissemination. These findings underscore the need for surveillance that resolves plasmid backbones and transferability, not only resistance gene presence. Keywords: Escherichia coli , intestinal colonization, bla NDM-5 , mcr-1.1 , IncX3, IncI2, conjugation

Schlagwörter

Stichwörter der Autor:innen

Escherichia coliIncI2IncX3blaNDM-5conjugationintestinal colonizationmcr-1.1

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, People's Republic of China.
  • School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of M…
  • Department of Laboratory Medicine, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, People's Republic of China.

ORCID-Profile: Tongxi Hu

Zitieren

APA

Bao, L., Hu, T., Zhang, Q., Lin, H., Yan, H., Gao, H., Liu, X., & Shangguan, Z. (2026). Convergence of Carbapenem and Colistin Resistance in Intestinal Escherichia coli ST167/ST2659 Driven by IncX3 blaNDM-5 and IncI2-Associated Mcr-1.1 Mobility. Infection and Drug Resistance, Volume 19, 1-8. https://doi.org/10.2147/idr.s594479

Vancouver

Bao L, Hu T, Zhang Q, Lin H, Yan H, Gao H, et al. Convergence of Carbapenem and Colistin Resistance in Intestinal Escherichia coli ST167/ST2659 Driven by IncX3 blaNDM-5 and IncI2-Associated Mcr-1.1 Mobility. Infection and Drug Resistance. 2026;Volume 19:1-8. doi:10.2147/idr.s594479

BibTeX
@article{Bao2026,
  author = {Bao, Lianmin and Hu, Tongxi and Zhang, Qing and Lin, Heping and Yan, Hanhan and Gao, Han and Liu, Xiaojing and Shangguan, Zongxiao},
  title = {Convergence of Carbapenem and Colistin Resistance in Intestinal Escherichia coli ST167/ST2659 Driven by IncX3 blaNDM-5 and IncI2-Associated Mcr-1.1 Mobility},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--8},
  doi = {10.2147/idr.s594479}
}
Kostenlos starten →